These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8132171)

  • 1. Cellular and molecular mechanisms in photochemical sensitization: studies on the mechanism of action of psoralens.
    Laskin JD
    Food Chem Toxicol; 1994 Feb; 32(2):119-27. PubMed ID: 8132171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding.
    Laskin JD; Lee E; Laskin DL; Gallo MA
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8211-5. PubMed ID: 3490664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralen binding and inhibition of epidermal growth factor binding by psoralen/ultraviolet light (PUVA) in human epithelial cells.
    Laskin JD; Lee E
    Biochem Pharmacol; 1991 Jan; 41(1):125-32. PubMed ID: 1846071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a photoalkylated psoralen receptor in HeLa cells.
    Yurkow EJ; Laskin JD
    J Biol Chem; 1987 Jun; 262(18):8439-42. PubMed ID: 3036814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of psoralens: isobologram analysis reveals that ultraviolet light potentiation of psoralen action is not additive but synergistic.
    Yurkow EJ; Laskin JD
    Cancer Chemother Pharmacol; 1991; 27(4):315-9. PubMed ID: 1998988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Psoralen Action in the Skin.
    Laskin JD
    J Am Coll Toxicol; 1989; 8(5):797-800. PubMed ID: 37396932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA.
    Laskin JD; Lee E; Yurkow EJ; Laskin DL; Gallo MA
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6158-62. PubMed ID: 3862124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of growth inhibition in keratinocytes by mercurio-substituted 4',5'-dihydropsoralens.
    Martey CA; Vetrano AM; Whittemore MS; Mariano TM; Gentile SL; Heck DE; Laskin DL; Heindel ND; Laskin JD
    Biochem Pharmacol; 2002 Jun; 63(11):2001-9. PubMed ID: 12093477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of active oxygen species (1O2 and O2-.) by psoralens and ultraviolet radiation (320-400 nm).
    Pathak MA; Joshi PC
    Biochim Biophys Acta; 1984 Mar; 798(1):115-26. PubMed ID: 6322854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous phototoxicity reactions.
    Lowe NJ
    Br J Dermatol; 1986 Aug; 115 Suppl 31():86-92. PubMed ID: 3741805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action spectra of topical psoralens: a re-evaluation.
    Cripps DJ; Lowe NJ; Lerner AB
    Br J Dermatol; 1982 Jul; 107(1):77-82. PubMed ID: 7104210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 8-methoxypsoralen and ultraviolet light A on EGF receptor (HER-1) expression.
    Yang XY; Ronai ZA; Santella RM; Weinstein IB
    Biochem Biophys Res Commun; 1988 Dec; 157(2):590-6. PubMed ID: 2462418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the nature of in vitro and in vivo photosensitization reactions by psoralens and porphyrins.
    Carraro C; Pathak MA
    J Invest Dermatol; 1988 Mar; 90(3):267-75. PubMed ID: 2831280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photosensitization of mammalian cells by psoralens and porphyrins.
    Moreno G
    Biochimie; 1986 Jun; 68(6):869-73. PubMed ID: 3092880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of epidermal growth factor binding by photoactivated psoralens and the tumor promoter 12-O-tetradecanoyl phorbol-13-acetate in cells overexpressing protein kinase C.
    Georgiadis C; Laskin JD
    Biochem Pharmacol; 1991 Oct; 42(10):2003-9. PubMed ID: 1741777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of controlled ultraviolet radiation in the treatment of dermatological diseases.
    Situm M; Bulat V; Majcen K; Dzapo A; Jezovita J
    Coll Antropol; 2014 Dec; 38(4):1249-53. PubMed ID: 25842770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoralenamines. 3. Synthesis, pharmacological behavior, and DNA binding of 5-(aminomethyl)-8-methoxy-, 5-[[(3-aminopropyl)oxy]methyl]-, and 8-[(3-aminopropyl)oxy]psoralen derivatives.
    Hansen JB; Bjerring P; Buchardt O; Ebbesen P; Kanstrup A; Karup G; Knudsen PH; Nielsen PE; Nordén B; Ygge B
    J Med Chem; 1985 Aug; 28(8):1001-10. PubMed ID: 4020822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nature and molecular basis of cutaneous photosensitivity reactions to psoralens and coal tar.
    Pathak MA; Joshi PC
    J Invest Dermatol; 1983 Jun; 80 Suppl():66s-74s. PubMed ID: 6854058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-impermeant pyridinium derivatives of psoralens as inhibitors of keratinocyte growth.
    Mariano TM; Vetrano AM; Gentile SL; Heck DE; Whittemore MS; Guillon CD; Jabin I; Rapp RD; Heindel ND; Laskin JD
    Biochem Pharmacol; 2002 Jan; 63(1):31-9. PubMed ID: 11754871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell membrane, a target for PUVA therapy.
    Zarebska Z
    J Photochem Photobiol B; 1994 May; 23(2-3):101-9. PubMed ID: 8040751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.